REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N319 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N319 OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Apteka N319 OOO is an enterprise in Russia, with the main office in Sergiev Posad. The company operates in the Pharmacies and Drug Stores industry. Apteka N319 OOO was incorporated on October 30, 1998. There are currently 3 (2022) people employed by Apteka N319 OOO. The company’s latest financial report indicates a net sales revenue drop of 91.5% in 2022. Its’ total assets recorded a negative growth of 98.46%.

Headquarters
Pobedy, 5
Sergiev Posad; Moscow Oblast; Postal Code: 141307

Contact Details: Purchase the Apteka N319 OOO report to view the information.

Basic Information
Total Employees:
Purchase the Apteka N319 OOO report to view the information.
Outstanding Shares:
Purchase the Apteka N319 OOO report to view the information.
Registered Capital:
Purchase the Apteka N319 OOO report to view the information.
Incorporation Date:
October 30, 1998
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka N319 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-91.5%
Total operating revenue
-91.5%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-98.46%
Total equity
-95.35%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?